These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 35801404)

  • 21. Short inhalation exposures of the isolated and perfused rat lung to respirable dry particle aerosols; the detailed pharmacokinetics of budesonide, formoterol, and terbutaline.
    Ewing P; Eirefelt SJ; Andersson P; Blomgren A; Ryrfeldt A; Gerde P
    J Aerosol Med Pulm Drug Deliv; 2008 Jun; 21(2):169-80. PubMed ID: 18518793
    [TBL] [Abstract][Full Text] [Related]  

  • 22. High-dose inhaled terbutaline in the management of chronic severe asthma: comparison of wet nebulisation and tube-spacer delivery.
    Prior JG; Nowell RV; Cochrane GM
    Thorax; 1982 Apr; 37(4):300-3. PubMed ID: 7112461
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effect of budesonide in combination with formoterol for reliever therapy in asthma exacerbations: a randomised controlled, double-blind study.
    Rabe KF; Atienza T; Magyar P; Larsson P; Jorup C; Lalloo UG
    Lancet; 2006 Aug; 368(9537):744-53. PubMed ID: 16935685
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A 4-week comparison of salmeterol and terbutaline in adult asthma.
    Hermansson BA; Jenkins RJ
    Allergy; 1995 Jul; 50(7):551-8. PubMed ID: 8588686
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The effect of terbutaline on the absorption of pulmonary administered insulin in subjects with asthma.
    Petersen AH; Korsatko S; Köhler G; Wutte A; Olschewski H; Sparre T; Råstam J; Wollmer P; Pieber TR
    Br J Clin Pharmacol; 2010 Mar; 69(3):271-8. PubMed ID: 20233198
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Factors affecting the release rate of terbutaline from liposome formulations after intratracheal instillation in the guinea pig.
    Fielding RM; Abra RM
    Pharm Res; 1992 Feb; 9(2):220-3. PubMed ID: 1553346
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Rapid reversibility of the allergen-induced pulmonary late-phase reaction by an intravenous beta2-agonist.
    Peebles RS; Permutt S; Togias A
    J Appl Physiol (1985); 1998 May; 84(5):1500-5. PubMed ID: 9572791
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Sustained-release terbutaline vs sustained-release theophylline in young patients with asthma.
    Roberts JR; Desai HI; Gillespie CA; Simons FE
    Am J Dis Child; 1986 Jul; 140(7):650-4. PubMed ID: 3717101
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Bambuterol, a bronchodilator prodrug with sustained action, enhances delivery of active drug to the lung.
    Svensson LA
    Agents Actions Suppl; 1988; 23():271-6. PubMed ID: 3262993
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Comparison of the effects of nebulized terbutaline with or without intravenous betamethasone on exhaled nitric oxide in children with acute asthma attack.
    Lee MY; Tsai YG; Yang KD; Hung CH
    J Microbiol Immunol Infect; 2006 Feb; 39(1):33-8. PubMed ID: 16440121
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Budesonide-formoterol reliever therapy versus maintenance budesonide plus terbutaline reliever therapy in adults with mild to moderate asthma (PRACTICAL): a 52-week, open-label, multicentre, superiority, randomised controlled trial.
    Hardy J; Baggott C; Fingleton J; Reddel HK; Hancox RJ; Harwood M; Corin A; Sparks J; Hall D; Sabbagh D; Mane S; Vohlidkova A; Martindale J; Williams M; Shirtcliffe P; Holliday M; Weatherall M; Beasley R;
    Lancet; 2019 Sep; 394(10202):919-928. PubMed ID: 31451207
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Efficacy of salbutamol by nebulizer versus metered dose inhaler with home-made non-valved spacer in acute exacerbation of childhood asthma.
    Yasmin S; Mollah AH; Basak R; Islam KT; Chowdhury YS
    Mymensingh Med J; 2012 Jan; 21(1):66-71. PubMed ID: 22314457
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Inhaled Combined Budesonide-Formoterol as Needed in Mild Asthma.
    O'Byrne PM; FitzGerald JM; Bateman ED; Barnes PJ; Zhong N; Keen C; Jorup C; Lamarca R; Ivanov S; Reddel HK
    N Engl J Med; 2018 May; 378(20):1865-1876. PubMed ID: 29768149
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Comparison of formoterol and terbutaline for as-needed treatment of asthma: a randomised trial.
    Tattersfield AE; Löfdahl CG; Postma DS; Eivindson A; Schreurs AG; Rasidakis A; Ekström T
    Lancet; 2001 Jan; 357(9252):257-61. PubMed ID: 11214127
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Use of functional respiratory imaging to characterize the effect of inhalation profile and particle size on lung deposition of inhaled corticosteroid/long-acting β2-agonists delivered via a pressurized metered-dose inhaler.
    Van Holsbeke C; De Backer J; Vos W; Marshall J
    Ther Adv Respir Dis; 2018; 12():1753466618760948. PubMed ID: 29499614
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Preparation, characterization and in vivo distribution of terbutaline sulfate loaded albumin microspheres.
    Sahin S; Selek H; Ponchel G; Ercan MT; Sargon M; Hincal AA; Kas HS
    J Control Release; 2002 Aug; 82(2-3):345-58. PubMed ID: 12175748
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Thirteen-year follow-up of early intervention with an inhaled corticosteroid in patients with asthma.
    Haahtela T; Tamminen K; Kava T; Malmberg LP; Rytilä P; Nikander K; Persson T; Selroos O
    J Allergy Clin Immunol; 2009 Dec; 124(6):1180-5. PubMed ID: 20004779
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Terbutaline depot tablets in asthma. A clinical evaluation.
    Taudorf E; Bundgaard A; Fagerström PO; Weeke E; Weeke B
    Allergy; 1981 Oct; 36(7):495-500. PubMed ID: 7039400
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Addition of terbutaline to optimal theophylline therapy. Double blind crossover study in asthmatic patients.
    Vandewalker ML; Kray KT; Weber RW; Nelson HS
    Chest; 1986 Aug; 90(2):198-203. PubMed ID: 3525022
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Raloxifene-loaded SLNs with enhanced biopharmaceutical potential: QbD-steered development, in vitro evaluation, in vivo pharmacokinetics, and IVIVC.
    Jain A; Sharma T; Kumar R; Katare OP; Singh B
    Drug Deliv Transl Res; 2022 May; 12(5):1136-1160. PubMed ID: 33966178
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.